Clinical Trial Update: Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety and tolerability of ascending intravenous doses of PF-05231023 in adults with Type 2 diabetes mellitus; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-05231023

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2015-01-12